ArticleNanomaterials (Basel, Switzerland)2026
AI-Driven Design and Comparative Evaluation of SNEDDS for the Optimized Nanoencapsulation of Phytoextracts.
Article in Nanomaterials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oil-in-water nanoemulsions (NE) can increase the water solubility of plant-derived bioactive molecules as drug candidates. Machine learning-guided NE design can prevent the expensive, time-consuming trial-and-error process. NE composition data was aggregated into a dataset; a predictive machine learning model identified improved self-nanoemulsifying system formulations (olive oil and combinations of Tween 20, Tween 80, glycerol, and soy lecithin). Predictive power was assessed by estimating successful self-nanoemulsification through transmittance and Dynamic Light Scattering. NEs were loaded with an organic extract containing anacardic acid. Encapsulation efficiency was measured by UHPLC. Antiproliferative activity was evaluated on human hepatic cancer (Hep G2) and normal-like human embryonic kidney (HEK-293) cell lines. The model showed an accuracy of 81%. The best-performing formulation, consisting of 10% olive oil, 60% Tween 20, and 30% glycerol, exhibited an average particle size of 162.8 ± 26 nm, a polydispersity index of 0.234 ± 0.03, and high encapsulation efficiency. While HEK-293 cells remained unaffected, naked NE exhibited a selective growth inhibitory effect on the Hep G2 cell line. Loaded NE increased the cytotoxic effect on Hep G2 (IC50: 5.9 ± 1.27 µM). Machine learning-guided NE formulation was a successful carrier for the plant extract and the molecule of interest, providing a proof of concept for how artificial intelligence can shorten the development pipeline for NE drug delivery systems.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.